Madras Diabetes Research Foundation and Dr. Mohan's Diabetes Specialities Centre, ICMR Center for Advanced Research on Diabetes, No 4, Conran Smith Road, Gopalapuram, Chennai, 600086, India.
Acta Diabetol. 2021 Aug;58(8):1051-1058. doi: 10.1007/s00592-021-01698-7. Epub 2021 Mar 23.
To investigate the risk of type 2 diabetes (T2DM) among the combinations of BMI categories and metabolic syndrome in Asian Indians.
Individuals from the Chennai Urban Rural Epidemiology Study cohort (n = 1,368), free of diabetes at baseline were stratified by BMI and metabolic health as metabolically healthy non-obese (MHNO), metabolically healthy obese (MHO), metabolically obese non-obese (MONO) and metabolically obese obese (MOO). Phenotypic obesity was defined as BMI ≥ 25 kg/m and metabolic obesity as presence of any two of the metabolic abnormalities: hyperglycemia, high blood pressure, high triglyceridemia or low HDL cholesterol. Hazard ratios for progression to diabetes were estimated using Cox proportional hazard regression.
During median 9.1 years of follow-up, incident cases of diabetes were highest among MOO-45.1%, followed by MONO-41.3%, MHO-27.1% and MHNO-15.9%. Incidence rates of diabetes among MOO, MONO, MHO and MHNO were 57.8, 50.9, 30.4 and 18.1 per 1000 person years, respectively. Hazard ratio for diabetes development were 1.71 in MHO, 2.87 in MONO, and 3.39 in MOO compared with MHNO.
Increased BMI and metabolic risk factor clustering independently contribute to the increased risk of T2DM in obese individuals. Screening for metabolic abnormalities should be performed routinely in clinic to identify high-risk individuals and institute appropriate preventive measures.
探讨亚洲印第安人群中 BMI 类别和代谢综合征组合与 2 型糖尿病(T2DM)风险的关系。
本研究对 Chennai Urban Rural Epidemiology Study 队列中的个体(n=1368)进行了分层,这些个体在基线时无糖尿病,根据 BMI 和代谢健康状况分为代谢健康非肥胖(MHNO)、代谢健康肥胖(MHO)、代谢肥胖非肥胖(MONO)和代谢肥胖肥胖(MOO)。表型肥胖定义为 BMI≥25kg/m²,代谢性肥胖定义为存在任何两种代谢异常:高血糖、高血压、高三酰甘油血症或低 HDL 胆固醇。使用 Cox 比例风险回归估计进展为糖尿病的风险比。
在中位 9.1 年的随访期间,MOO 组的糖尿病发生率最高(45.1%),其次是 MONO 组(41.3%)、MHO 组(27.1%)和 MHNO 组(15.9%)。MOO、MONO、MHO 和 MHNO 组的糖尿病发生率分别为 57.8、50.9、30.4 和 18.1/1000 人年。与 MHNO 相比,MHO、MONO 和 MOO 发生糖尿病的风险比分别为 1.71、2.87 和 3.39。
BMI 增加和代谢危险因素聚集独立增加肥胖个体发生 T2DM 的风险。应常规在临床中进行代谢异常筛查,以识别高危个体并采取适当的预防措施。